Review
Aug 2026
Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities
Current evidence supports continued investigation of semaglutide as a potential neuroprotective strategy, while highlighting the need for earlier intervention studies, improved understanding of CNS target engagement, and further clinical validation.
R. D. Mukim, Ya-Ma Y. Xu, V. Evola et al.
· Molecular Biology Reports · 1 citation